Genecast is a leading precision oncology diagnostics company based in China, specializing in the development and clinical implementation of molecular assays across the full cancer care continuum, including early detection, therapy selection, prognosis, and recurrence monitoring. The company's test portfolio integrates multiplex PCR and hybrid-capture-based targeted NGS to profile cancer mutations from both tissue DNA and RNA, as well as liquid biopsy samples. 

Leveraging high-throughput sequencing, proprietary bioinformatics, and translational research, Genecast offers precision oncology solutions covering over 20+ cancer types. Genecast delivers diagnostic insights to hospitals, clinical labs, and research partners worldwide, supporting personalized cancer care. The company leads China in multi-omics oncology testing and holds certifications under CAP, ISO, CE-IVD, and NMPA.